ArticleEuropean journal of heart failure2025

Safety and tolerability of sacubitril/valsartan in chronic heart failure and reduced ejection fraction: Results from the open-label extension of the PARADIGM-HF study.

Michele Senni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.